NCT04708275

Brief Summary

Depression often occurs in early childhood. Moreover, later depression is frequently preceded by early childhood Depression (ECD). However, at present, there is a lack of evidence-based tratestments (EBTs) for ECD, posing a core research desideratum highlighted by both the American and German practice parameters for ECD. The current study seeks to redress this research gap, by evaluating the feasibility and dose-dependent effectiveness of manualized short-term psychoanalytic child psychotherapy (PaCT) compared to waitlist in a randomized controlled trial (RCT) among clinically referred 3 to 8-year-olds with ECD. Comprising 20-25 sessions in alternating settings (child-only, caregiver(s)-child, caregiver(s)-only), PaCT focuses on internal conflicts and representations underlying depressive disorders. PaCT targets the child-therapist relationship, using interpretative, play and mentalization-based techniques, aiming to elicit the interpersonal meaning of the child's symptoms within the child-caregiver relationship(s).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

February 24, 2020

Completed
11 months until next milestone

First Posted

Study publicly available on registry

January 13, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2024

Completed
Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

4.2 years

First QC Date

February 24, 2020

Last Update Submit

June 11, 2025

Conditions

Keywords

Early Childhood Depression

Outcome Measures

Primary Outcomes (1)

  • Sum of depressive symptoms as indexed by the Preschool Age Psychiatric Assessment (PAPA) interview with the primary caregiver

    Sum of depressive symptoms using Preschool Age Psychiatric Assessment (PAPA) at post-treatment in the treatment group compared to post-waiting period in the waitlist group (controlling for the respective pre-values) based on clinical interviews. The scale ranges from 0-9 symptoms and higher values indicate worse outcome.

    post-treatment (after 20-25 weeks with weekly treatment sessions; on average after 7 months)

Secondary Outcomes (12)

  • Sum of PAPA depressive symptoms

    mid-treatment (after 12 weeks with weekly treatment sessions) and follow up (3 months after intervention)

  • Diagnosis of depression

    mid-treatment (after 12 weeks with weekly treatment sessions) and follow up (3 months after intervention)

  • Diagnosis of anxiety disorder

    pre-waitlist (before waiting period) / pre-treatment (within 3 weeks before start of intervention), post-treatment (after 20-25 weeks with weekly treatment sessions) and follow up (3 months after intervention)

  • Teacher-reported internalizing symptoms (TRF)

    pre-waitlist (before waiting period)/pre-treatment (within 3 weeks before start intervention)/mid-treatment (after 12 weeks with weekly treatment sessions)/post-treatment (after 20-25 weeks with weekly treatment sessions)/FUP (3 months post intervention)

  • Interview-based internalizing symptoms

    pre-waitlist (before waiting period), pre-treatment (within 3 weeks before start intervention), post-treatment (after 20-25 weeks with weekly treatment sessions), follow-up (3 months after intervention)

  • +7 more secondary outcomes

Other Outcomes (5)

  • Feasibility-related endpoints - Acceptability of PaCT

    post-treatment (after 20-25 weeks with weekly treatment sessions)

  • Feasibility-related endpoints - Acceptability of PaCT rated by children

    post-treatment (after 20-25 weeks with weekly treatment sessions)

  • Feasibility-related endpoints - Acceptability of PaCT rated by therapists

    post-treatment (after 20-25 weeks with weekly treatment sessions)

  • +2 more other outcomes

Study Arms (2)

PaCT

EXPERIMENTAL

Manualized Psychoanalytic short-term therapy (PaCT) for children with internalizing disorders, 20-25 sessions (1, 2). PaCT helps the child to resolve rigid conflictual internal representations/ working models by using interpretative and mentalizing techniques and drawing on therapeutic transference relationship with the child and the parent.

Procedure: PaCT

Waitlist

ACTIVE COMPARATOR

PaCT after a waiting period (3 months)

Procedure: PaCT

Interventions

PaCTPROCEDURE

Manualized Psychoanalytic short-term therapy (PaCT) for children with internalizing disorders, 20-25 sessions (1, 2). PaCT helps the child to resolve rigid conflictual internal representations/ working models by using interpretative and mentalizing techniques and drawing on therapeutic transference relationship with the child and the parent.

PaCTWaitlist

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 3 to 8 years
  • DSM-5 depressive disorder (Major Depression, Dysthymia, Depression NOS), adapted for young children according to the AACAP criteria
  • Written informed consent of patient's parents or guardian
  • informed verbal assent from children (age \>= 6 years)

You may not qualify if:

  • IQ \< 70
  • autism spectrum or schizophrenia spectrum disorder in the child
  • insufficient German language skills to participate in treatment (child or caregiver)
  • ongoing litigation regarding child custody
  • concurrent intensive psychotherapy
  • participation in other interventional trials
  • suspected lack of compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Leipzig - Department of Child and Adolescent Psychiatry

Leipzig, 04103, Germany

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Kai von Klitzing, Prof.Dr.

    University of Leipzig - Department of Child and Adolescent Psychiatry

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 arms, waitlist-controlled, randomized, single masked (outcomes assessor), single-center trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinating Investigator

Study Record Dates

First Submitted

February 24, 2020

First Posted

January 13, 2021

Study Start

February 24, 2020

Primary Completion

May 2, 2024

Study Completion

May 2, 2024

Last Updated

June 15, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

After publication of the primary objective, published data might be provided to interested scientists on request (e.g. for meta-analyses, health related registers or other scientific questions) in an anonymized way within 5 years, if the members of the TREAT-SAD-KIDS-trial group agree.

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
after publication within 5 years
Access Criteria
direct inquiry to coordinating investigators

Locations